Our advertisers

Baxter Healthcare Ltd
Medela AG
Armstrong Medical
Vygon (UK) Ltd
ParAid
Inspiration Healthcare
Solus Medical Limited
Intersurgical Ltd
Central Medical Supplies Ltd
SBK (UK) Ltd
CliniMed Limited
vCreate Neonatal
Nutricia Ltd
University of Plymouth

 

 

Volume 15/Issue 4, July 2019

The changing picture of neonatal abstinence syndrome: ‘new drugs on the block’

Rachel Toone, Kathryn Johnson, Cath Harrison


Neonatal abstinence syndrome (NAS) is usually associated with maternal opioid use but the pattern of drug use is changing, with many affected infants now having been exposed to new psychoactive substances in utero. This article will focus on emerging recreational substances, particularly synthetic cannabinoids, the challenges faced in the management of NAS in these cases, and the potential long-term consequences.

Toone R., Johnson K., Harrison C. The changing picture of neonatal abstinence syndrome: ‘new drugs on the block’. Infant 2019;15(4): 138-40.
Abbreviated: Please subscribe and log in to see the full article.

 
© Copyright of Stansted News Limited 2019. Terms & Conditions of reading. Privacy policy